Primary Job Title Consulting, Science/Scientist Primary Organization 
Sevo Nutraceuticals
Gender Male
PERCEPTIV® is the result of 20 years of research, led by Dr. Thomas Shea, Director of the Center for Cellular Neurobiology & Neurodegeneration Research at the University of Massachusetts-Lowell. Previous to UMASS, Dr. Shea studied at Harvard Medical School focusing on the development of the nervous system.
Dr. Shea conducted 7 independent
clinical studies on the PERCEPTIV® formula. 6 of the studies are published in peer-reviewed scientific journals, including a phase II study funded by the Alzheimer's Association, and an additional study is pending publication.
Over the past 20 years, Dr. Shea has led to the publication of more than 60 scientific reports and to the development and patenting of the PERCEPTIV® formulation. He has also contributed to over 300 additional healthcare publications surrounding brain function and health.
